48 related articles for article (PubMed ID: 21119597)
21. Integrative analysis of cancer prognosis data with multiple subtypes using regularized gradient descent.
Ma S; Zhang Y; Huang J; Huang Y; Lan Q; Rothman N; Zheng T
Genet Epidemiol; 2012 Dec; 36(8):829-38. PubMed ID: 22851516
[TBL] [Abstract][Full Text] [Related]
22. Hodgkin's lymphoma RNA-transfected dendritic cells induce cancer/testis antigen-specific immune responses.
Winkler C; Steingrube DS; Altermann W; Schlaf G; Max D; Kewitz S; Emmer A; Kornhuber M; Banning-Eichenseer U; Staege MS
Cancer Immunol Immunother; 2012 Oct; 61(10):1769-79. PubMed ID: 22419371
[TBL] [Abstract][Full Text] [Related]
23. Notch1 regulates the expression of the multidrug resistance gene ABCC1/MRP1 in cultured cancer cells.
Cho S; Lu M; He X; Ee PL; Bhat U; Schneider E; Miele L; Beck WT
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20778-83. PubMed ID: 22143792
[TBL] [Abstract][Full Text] [Related]
24. Mastermind-like 1 Is a specific coactivator of beta-catenin transcription activation and is essential for colon carcinoma cell survival.
Alves-Guerra MC; Ronchini C; Capobianco AJ
Cancer Res; 2007 Sep; 67(18):8690-8. PubMed ID: 17875709
[TBL] [Abstract][Full Text] [Related]
25. Crystal structure of the CSL-Notch-Mastermind ternary complex bound to DNA.
Wilson JJ; Kovall RA
Cell; 2006 Mar; 124(5):985-96. PubMed ID: 16530045
[TBL] [Abstract][Full Text] [Related]
26. Mastermind-like 1 (MamL1) and mastermind-like 3 (MamL3) are essential for Notch signaling in vivo.
Oyama T; Harigaya K; Sasaki N; Okamura Y; Kokubo H; Saga Y; Hozumi K; Suganami A; Tamura Y; Nagase T; Koga H; Nishimura M; Sakamoto R; Sato M; Yoshida N; Kitagawa M
Development; 2011 Dec; 138(23):5235-46. PubMed ID: 22069191
[TBL] [Abstract][Full Text] [Related]
27. The repression of Notch signaling occurs via the destabilization of mastermind-like 1 by Mesp2 and is essential for somitogenesis.
Sasaki N; Kiso M; Kitagawa M; Saga Y
Development; 2011 Jan; 138(1):55-64. PubMed ID: 21098559
[TBL] [Abstract][Full Text] [Related]
28. Identification of a family of mastermind-like transcriptional coactivators for mammalian notch receptors.
Wu L; Sun T; Kobayashi K; Gao P; Griffin JD
Mol Cell Biol; 2002 Nov; 22(21):7688-700. PubMed ID: 12370315
[TBL] [Abstract][Full Text] [Related]
29. High-level expression of Mastermind-like 2 contributes to aberrant activation of the NOTCH signaling pathway in human lymphomas.
Köchert K; Ullrich K; Kreher S; Aster JC; Kitagawa M; Jöhrens K; Anagnostopoulos I; Jundt F; Lamprecht B; Zimber-Strobl U; Stein H; Janz M; Dörken B; Mathas S
Oncogene; 2011 Apr; 30(15):1831-40. PubMed ID: 21119597
[TBL] [Abstract][Full Text] [Related]
30. Notch signalling in the nucleus: roles of Mastermind-like (MAML) transcriptional coactivators.
Kitagawa M
J Biochem; 2016 Mar; 159(3):287-94. PubMed ID: 26711237
[TBL] [Abstract][Full Text] [Related]
31. More complicated than it looks: assembly of Notch pathway transcription complexes.
Kovall RA
Oncogene; 2008 Sep; 27(38):5099-109. PubMed ID: 18758478
[TBL] [Abstract][Full Text] [Related]
32. Mastermind-like transcriptional co-activators: emerging roles in regulating cross talk among multiple signaling pathways.
McElhinny AS; Li JL; Wu L
Oncogene; 2008 Sep; 27(38):5138-47. PubMed ID: 18758483
[TBL] [Abstract][Full Text] [Related]
33. Notch signaling in leukemias and lymphomas.
Jundt F; Schwarzer R; Dörken B
Curr Mol Med; 2008 Feb; 8(1):51-9. PubMed ID: 18289013
[TBL] [Abstract][Full Text] [Related]
34.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
35.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
